NCT04176679View on ClinicalTrials.gov

Diagnosis and Management of Enhanced Myometrial Vascularity Associated With Retained Products of Conception

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

October 1, 2019

Study Completion Date

November 1, 2019

Conditions

Hypervascularized Uterine Retentions

Trial Locations (1)

34295

Uh Montpellier, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER

NCT04176679 - Diagnosis and Management of Enhanced Myometrial Vascularity Associated With Retained Products of Conception | Biotech Hunter | Biotech Hunter